# Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation

> **NCT01579097** · PHASE3 · COMPLETED · sponsor: **Baxter Healthcare Corporation** · enrollment: 458 (actual)

## Conditions studied

- Nutrition Support

## Interventions

- **OTHER:** Oliclinomel N4
- **OTHER:** Compounded ternary parenteral nutrition admixtures

## Key facts

- **NCT ID:** NCT01579097
- **Lead sponsor:** Baxter Healthcare Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12
- **Primary completion:** 2012-11
- **Final completion:** 2013-01
- **Target enrollment:** 458 (ACTUAL)
- **Last updated:** 2013-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01579097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01579097, "Comparative Phase 3 Trial to Assess the Safety and Efficacy of Triple-chamber Parenteral Nutrition Formulation". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01579097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*